Las Vegas, NV · Founded 2015 · Privately Held (backing)
Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics. Heligenics is based in Las Vegas, NV and was founded in 2015. Its last reported valuation was $17.2 million in Aug 2022. It has raised $6 million across 3 recorded rounds; the latest was a $2.6 million seed round in Aug 2024.
Last reported valuation
$17.2M
Oct 2026
Priced at
—
Total raised
$6.0M
Last round
Seed Round
Aug 2024
No prints on record
No secondary trades in Heligenics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Heligenics with a free account
·Watch Heligenics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Heligenics stock.
